Search details
1.
Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy.
Pharmacol Res
; 182: 106324, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35750301
2.
A comparative study of pericardial effusion and pleural effusion after cryoballoon ablation or radiofrequency catheter ablation of atrial fibrillation.
J Cardiovasc Electrophysiol
; 31(5): 1062-1067, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32108393
3.
Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.
Acta Pharmacol Sin
; 40(8): 1067-1075, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-30670815
4.
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
J Pharmacol Exp Ther
; 365(3): 494-506, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29602831
5.
A long noncoding RNA connects c-Myc to tumor metabolism.
Proc Natl Acad Sci U S A
; 111(52): 18697-702, 2014 Dec 30.
Article
in English
| MEDLINE | ID: mdl-25512540
6.
LDL Receptor-Related Protein 6 Modulates Ret Proto-Oncogene Signaling in Renal Development and Cystic Dysplasia.
J Am Soc Nephrol
; 27(2): 417-27, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26047795
7.
JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation.
Biochim Biophys Acta
; 1853(10 Pt A): 2286-95, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26025680
8.
Pax6 mediates ß-catenin signaling for self-renewal and neurogenesis by neocortical radial glial stem cells.
Stem Cells
; 32(1): 45-58, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24115331
9.
Lin28 promotes growth of prostate cancer cells and activates the androgen receptor.
Am J Pathol
; 183(1): 288-95, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23790802
10.
The integrated bioinformatic analysis identifies immune microenvironment-related potential biomarkers for patients with gestational diabetes mellitus.
Front Immunol
; 15: 1296855, 2024.
Article
in English
| MEDLINE | ID: mdl-38449866
11.
Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma.
Cell Rep Med
; 5(5): 101519, 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38692271
12.
Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.
Prostate
; 73(5): 455-66, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23038103
13.
KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation.
Proc Natl Acad Sci U S A
; 107(21): 9671-6, 2010 May 25.
Article
in English
| MEDLINE | ID: mdl-20457893
14.
[Clinical characteristics and long-term outcome of non-pulmonary vein foci ablation in patients with paroxysmal atrial fibrillation].
Zhonghua Xin Xue Guan Bing Za Zhi
; 41(11): 922-6, 2013 Nov.
Article
in Zh
| MEDLINE | ID: mdl-24370218
15.
[Catheter ablation of epicardial accessory pathway associated with coronary sinus musculature].
Zhonghua Xin Xue Guan Bing Za Zhi
; 41(5): 377-81, 2013 May.
Article
in Zh
| MEDLINE | ID: mdl-24021118
16.
[Efficacy of catheter radiofrequency ablation for the treatment of ventricular arrhythmia storm post cardioverter-defibrillators implantation].
Zhonghua Xin Xue Guan Bing Za Zhi
; 41(3): 233-8, 2013 Mar.
Article
in Zh
| MEDLINE | ID: mdl-23879950
17.
Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner.
Front Pharmacol
; 14: 1146741, 2023.
Article
in English
| MEDLINE | ID: mdl-37180705
18.
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer.
Acta Pharm Sin B
; 13(10): 4273-4290, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37799388
19.
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment.
J Immunother Cancer
; 11(5)2023 05.
Article
in English
| MEDLINE | ID: mdl-37147019
20.
Discovery of a highly potent and orally available importin-ß1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer.
Acta Pharm Sin B
; 13(12): 4934-4944, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38045040